% | $
Quotes you view appear here for quick access.

CEL-SCI Corporation Message Board

  • onconasty onconasty Oct 28, 2009 1:31 AM Flag

    very simply put


    A couple of months ago this little beauty looked to most like it would live out it's days as a penny stock. Unable to raise funds for a long delayed pivotal phase III trial, and struggling to avoid delisting and eviction, prospects looked bleak.

    Things have changed. Now there are ample funds to launch phase III for Multikine; to pay for LEAPS research that could result in EUA for H1N1; and funds to pay for further development of a rheumatoid arthritis treatment that could soon bring a very lucrative global licensing agreement, which could lead to a general recognition that the potential of the LEAPS platform to produce blockbuster drugs for infectious and autoimmune diseases is enormous.

    What's the downside here? I don't see it going below a buck. So from here, you might lose a quarter. What's the upside? You do your own math. I am not going anywhere, until I see how this plays out for at least the next three months.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.565+0.015(+2.69%)May 3 4:00 PMEDT